Jakob S M, Ruokonen E, Vuolteenaho O, Lampainen E, Takala J
Critical Care Research Program, Department of Anesthesiology and Intensive Care, Kuopio University Hospital, Kuopio, Finland.
Crit Care Med. 2001 Jul;29(7):1393-8. doi: 10.1097/00003246-200107000-00015.
Splanchnic perfusion may be compromised during hemodialysis because of hypovolemia, inflammatory response, and blood flow redistribution. The aim of this study was to assess the response of splanchnic blood flow and oxygen transport to hemodialysis.
A prospective clinical study.
A mixed medical-surgical intensive care unit in a university hospital.
Nine patients with acute renal failure.
A 4-hr period of hemodialysis.
Systemic (via a pulmonary artery catheter), hepatosplanchnic, and femoral (via dye dilution) blood flow and gastric mucosal Pco2 were measured before, during, and 2 hrs after hemodialysis. During hemodialysis, despite unchanged arterial blood pressure, cardiac output and stroke volume decreased from 3.0 +/- 1.0 L/m2/min (mean +/- sd) to 2.3 +/- 0.7 L/m2/min (p =.02), and from 38 +/- 16 mL/m2/min to 28 +/- 12 mL/m2/min (p =.01), respectively. Splanchnic but not femoral blood flow decreased from 0.9 +/- 0.3 L/m2/min to 0.7 +/- 0.2 L/m2/min (p =.02). The blood flows returned to baseline values after dialysis without need for therapeutic interventions. Gastric mucosal-arterial Pco2 gradients were high before dialysis (35 +/- 23 torr [4.6 +/- 3.1 kPa]) and did not change. Renin but not atrial natriuretic peptide concentration increased during hemodialysis from 13 +/- 13 microg/L to 35 +/- 40 microg/L and decreased afterward to baseline values (13 +/- 13 microg/L; p =.01). Whereas interleukin 6 tended to decrease, tumor necrosis factor alpha increased during hemodialysis from 74 +/- 24 pg/mL to 86 +/- 31 pg/mL and continued to increase after hemodialysis to 108 +/- 66 pg/mL (p =.022).
Hemodialysis and fluid removal in normotensive patients with acute renal failure may result in a reduction of systemic and splanchnic blood flow that is undetectable using traditional clinical signs. In contrast to what is observed in hypovolemia, the changes in regional blood flow are rapidly reversible after hemodialysis.
由于血容量不足、炎症反应和血流重新分布,血液透析期间内脏灌注可能受损。本研究的目的是评估内脏血流和氧输送对血液透析的反应。
一项前瞻性临床研究。
一所大学医院的内科-外科混合重症监护病房。
9例急性肾衰竭患者。
进行4小时的血液透析。
在血液透析前、透析期间及透析后2小时测量全身(通过肺动脉导管)、肝内脏和股部(通过染料稀释法)血流以及胃黏膜Pco2。血液透析期间,尽管动脉血压未变,但心输出量和每搏输出量分别从3.0±1.0L/m²/min(均值±标准差)降至2.3±0.7L/m²/min(p = 0.02),以及从38±16mL/m²/min降至28±12mL/m²/min(p = 0.01)。内脏血流而非股部血流从0.9±0.3L/m²/min降至0.7±0.2L/m²/min(p = 0.02)。透析后血流无需治疗干预即恢复至基线值。透析前胃黏膜-动脉Pco2梯度较高(35±23托[4.6±3.1kPa])且未改变。血液透析期间肾素浓度从13±13μg/L增至35±40μg/L,心房利钠肽浓度未变,透析后肾素浓度降至基线值(13±13μg/L;p = 0.01)。白细胞介素6有下降趋势,而肿瘤坏死因子α在血液透析期间从74±24pg/mL增至86±31pg/mL,并在透析后继续增至108±66pg/mL(p = 0.022)。
急性肾衰竭的血压正常患者进行血液透析和液体清除可能导致全身和内脏血流减少,而这用传统临床体征无法检测到。与血容量不足时观察到的情况不同,血液透析后局部血流变化可迅速逆转。